- Home
- Medimmune Ventures, Inc.
Insider Trading History of Medimmune Ventures, Inc.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Medimmune Ventures, Inc. since 2014.
The trader's CIK number is 1291884.
At the time of the last reporting, Medimmune Ventures, Inc. was the 10% Owner of G1 Therapeutics, Inc.. (stock ticker symbol GTHX).
Also see all insider trading activities at G1 Therapeutics, Inc..
Note that in the past
MedImmune Ventures, Inc. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Catabasis Pharmaceuticals Inc (CATB) by Medimmune Ventures, Inc.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | CATB | 223,439 | $2,681,268 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at G1 Therapeutics, Inc. (GTHX) by Medimmune Ventures, Inc.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | GTHX | 75,000 | $1,125,000 | 533,906 | $10,596,643 | 0 | $0 |
Yearly summary of insider trading at Rocket Pharmaceuticals, Inc. (ITEK) by Medimmune Ventures, Inc.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | ITEK | 416,667 | $2,500,002 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Applied Genetic Technologies Corp (AGTC) by Medimmune Ventures, Inc.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | AGTC | 75,735 | $908,820 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Medimmune Ventures, Inc.:
1. Catabasis Pharmaceuticals Inc (CATB)
2. G1 Therapeutics, Inc. (GTHX)
3. Rocket Pharmaceuticals, Inc. (ITEK)
4. Applied Genetic Technologies Corp (AGTC)
Table 1. Insider trading of Catabasis Pharmaceuticals Inc (CATB) by Medimmune Ventures, Inc.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-06-30 | CATB | Buy | 223,439 | 12.00 | 2,681,268 |
Table 2. Insider trading of G1 Therapeutics, Inc. (GTHX) by Medimmune Ventures, Inc.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-12-15 | GTHX | Sale | 200,000 | 19.75 | 3,950,000 |
| 2017-12-01 | GTHX | Sale | 133,906 | 19.75 | 2,644,643 |
| 2017-11-20 | GTHX | Sale | 200,000 | 20.01 | 4,002,000 |
| 2017-05-22 | GTHX | Buy | 75,000 | 15.00 | 1,125,000 |
Table 3. Insider trading of Rocket Pharmaceuticals, Inc. (ITEK) by Medimmune Ventures, Inc.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-02-23 | ITEK | Buy | 416,667 | 6.00 | 2,500,002 |
Table 4. Insider trading of Applied Genetic Technologies Corp (AGTC) by Medimmune Ventures, Inc.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-04-01 | AGTC | Buy | 75,735 | 12.00 | 908,820 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Medimmune Ventures, Inc.
(10% Owner of G1 Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.